Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

InnoCare Announces First Pediatric Patient Dosed in Clinical Trial of pan-TRK Inhibitor Zurletrectinib in China

PharmaSourcesJanuary 24, 2024

Tag: Zurletrectinib , InnoCare , Trial of pan-TRK Inhibitor

PharmaSources Customer Service